Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Conference item |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
American Heart Association
2022
|
| Özet: |
|---|